Citigroup’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.98K Buy
581
+169
+41% +$3.48K ﹤0.01% 5037
2025
Q4
$9.62K Buy
412
+259
+169% +$6.69K ﹤0.01% 5071
2025
Q3
$4.86K Sell
153
-931
-86% -$28.1K ﹤0.01% 5240
2025
Q2
$30.8K Sell
1,084
-1,827
-63% -$54.8K ﹤0.01% 4972
2025
Q1
$89.9K Sell
2,911
-372
-11% -$12.6K ﹤0.01% 4663
2024
Q4
$109K Buy
3,283
+365
+13% +$12.4K ﹤0.01% 4795
2024
Q3
$88.2K Buy
2,918
+2,015
+223% +$62.8K ﹤0.01% 4813
2024
Q2
$25.5K Buy
903
+260
+40% +$8.16K ﹤0.01% 4925
2024
Q1
$23.8K Buy
643
+71
+12% +$2.65K ﹤0.01% 4978
2023
Q4
$23.5K Buy
572
+569
+18,967% +$18.3K ﹤0.01% 4922
2023
Q3
$93 Sell
3
-1,127
-100% -$43.6K ﹤0.01% 5426
2023
Q2
$45.3K Sell
1,130
-8,988
-89% -$368K ﹤0.01% 4698
2023
Q1
$417K Buy
10,118
+859
+9% +$36.2K ﹤0.01% 3252
2022
Q4
$421K Buy
9,259
+8,313
+879% +$286K ﹤0.01% 3287
2022
Q3
$28K Buy
+946
New +$26.5K ﹤0.01% 4618
2021
Q2
Sell
-1,435
Closed -$45K 6379
2021
Q1
$45K Sell
1,435
-269
-16% -$9.32K ﹤0.01% 4757
2020
Q4
$85K Buy
+1,704
New +$67.1K ﹤0.01% 5659

Other funds holding SMTI

Citigroup's SMTI Position: Q1 2026 in Review

Citigroup increased its Sanara MedTech (SMTI) stake by 41% in Q1 2026, buying an estimated $3.48K and bringing the position to 581 shares worth $9.98K. The position accounts for ﹤0.01% of the portfolio, ranked #5037.

Citigroup first reported a position in SMTI in Q4 2020 and has held it in 17 quarters since. The position peaked at $421K in Q4 2022. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Citigroup held 581 shares of Sanara MedTech worth $9.98K as of Q1 2026.
  • Citigroup bought 169 Sanara MedTech shares in Q1 2026, an estimated $3.48K.
  • Sanara MedTech made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5037 holding.
  • Citigroup first reported a position in Sanara MedTech in Q4 2020 and has held it in 17 quarters since.
  • Citigroup's Sanara MedTech position peaked at $421K in Q4 2022.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.